光正眼科(002524) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥199,537,963.66, a decrease of 7.78% compared to ¥216,369,656.47 in the same period last year[5] - The net loss attributable to shareholders for Q1 2024 was ¥18,726,197.86, representing a 138.57% increase in loss compared to ¥7,849,394.18 in the previous year[5] - The company's net profit for Q1 2024 was -19,115,670.01 CNY, compared to -7,320,471.91 CNY in Q1 2023, representing a significant increase in net loss of approximately 161.5%[17] - The operating profit for Q1 2024 was -18,665,964.13 CNY, worsening from -6,309,366.67 CNY in the same period last year, reflecting a decline of approximately 196.5%[17] - The total cash flow from operating activities for Q1 2024 was -6,135,808.25 CNY, a decrease from 2,394,751.79 CNY in Q1 2023, indicating a negative shift in cash flow[20] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥1,514,657,931.31, down 2.24% from ¥1,549,365,088.25 at the end of the previous year[5] - Total liabilities decreased to CNY 1,243,697,466.84 from CNY 1,263,462,691.96, a decline of 1.6%[15] - The total equity attributable to shareholders decreased to CNY 268,611,237.00 from CNY 283,257,684.81, a drop of 5.2%[15] Cash and Cash Equivalents - The net cash flow from operating activities was -¥6,135,808.25, a decline of 356.22% from ¥2,394,751.79 in the same period last year[5] - Cash and cash equivalents decreased to CNY 65,054,312.47 from CNY 91,062,369.05 at the beginning of the quarter, representing a decline of 28.6%[13] - The company reported a total cash and cash equivalents balance of 41,598,822.55 CNY at the end of Q1 2024, down from 70,508,921.60 CNY at the end of Q1 2023, a decline of approximately 41.0%[20] Inventory and Contract Liabilities - The company's inventory increased by 35.26% to ¥40,068,311.04, primarily due to an increase in finished products in the steel structure segment[8] - Contract liabilities rose by 43.34% to ¥14,704,795.00, attributed to increased advance payments for steel structure processing[8] - The company reported a significant increase in contract liabilities to CNY 14,704,795.00 from CNY 10,258,342.60, reflecting a growth of 43.9%[15] Investment and Expenses - Investment income for Q1 2024 was ¥3,567,967.04, a significant increase of 392.31% compared to a loss of ¥1,220,611.38 in the previous year[8] - Research and development expenses for Q1 2024 were 292,573.94 CNY, with no prior year comparison available, indicating ongoing investment in innovation[17] - The company incurred sales expenses of 43,412,408.19 CNY in Q1 2024, an increase of approximately 11.5% from 38,998,809.22 CNY in Q1 2023[17] - The financial expenses for Q1 2024 were 9,817,709.61 CNY, slightly up from 9,469,528.00 CNY in Q1 2023, reflecting an increase of about 3.7%[17] Return on Assets - The weighted average return on net assets was -6.84%, a decrease of 3.88% compared to -2.96% in the same period last year[5] - The company reported a significant increase in credit impairment losses of 1436.38%, amounting to ¥518,951.32, due to provisions for bad debts in the steel structure segment[8] Accounts Receivable - Accounts receivable increased to CNY 125,005,391.24 from CNY 119,251,416.51, reflecting a growth of 4.7%[14]